Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. (FNCH) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 31 transactions totaling $31.4M, demonstrating a bullish sentiment with $31.4M in net insider flow. The most recent transaction on Jun 7, 2024 involved a transaction of 383 shares valued at $0.
FNCH Insider Activity Summary
Who Is Buying FNCH Stock?
No significant insider buying has been recorded for FNCH in the recent period.
Who Is Selling FNCH Stock?
No significant insider selling has been recorded for FNCH in the recent period.
Is Finch Therapeutics Group, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for FNCH is bullish with an Insider Alignment Score of 100/100 and a net flow of $31.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
FNCH Frequently Asked Questions
Understanding FNCH Insider Activity
Insider trading at Finch Therapeutics Group, Inc. (FNCH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading FNCH stock, having executed 31 transactions in the past 90 days. The most active insider is Nicholas Haft (Executive), who has made 8 transactions totaling $15.6M.
Related Tools
Track Finch Therapeutics Group, Inc. Insider Activity
Get notified when executives and directors at FNCH file new Form 4 transactions